247 related articles for article (PubMed ID: 9294848)
21. Fas ligand expression by maternal decidual cells is negatively correlated with the abundance of leukocytes present at the maternal-fetal interface.
Qiu Q; Yang M; Tsang BK; Gruslin A
J Reprod Immunol; 2005 Apr; 65(2):121-32. PubMed ID: 15811517
[TBL] [Abstract][Full Text] [Related]
22. Differential expressions of Fas and Fas ligand in human placenta.
Roh CR; Lee JW; Kang BH; Yang SH; Kim BG; Bae DS; Kim JH; Lee JH
J Korean Med Sci; 2002 Apr; 17(2):213-6. PubMed ID: 11961305
[TBL] [Abstract][Full Text] [Related]
23. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
[TBL] [Abstract][Full Text] [Related]
24. Fetal growth restriction is associated with reduced FasL expression by decidual cells.
Eide IP; Isaksen CV; Salvesen KA; Langaas M; Günther CC; Iversen AC; Austgulen R
J Reprod Immunol; 2007 Jun; 74(1-2):7-14. PubMed ID: 17196256
[TBL] [Abstract][Full Text] [Related]
25. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues.
Xerri L; Devilard E; Hassoun J; Mawas C; Birg F
Mol Pathol; 1997 Apr; 50(2):87-91. PubMed ID: 9231156
[TBL] [Abstract][Full Text] [Related]
26. Expression of Fas/Fas-ligand, Bcl-2 protein and apoptosis in extravillous trophoblast along invasion to the decidua in human term placenta.
Murakoshi H; Matsuo H; Laoag-Fernandez JB; Samoto T; Maruo T
Endocr J; 2003 Apr; 50(2):199-207. PubMed ID: 12803240
[TBL] [Abstract][Full Text] [Related]
27. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Hahne M; Rimoldi D; Schröter M; Romero P; Schreier M; French LE; Schneider P; Bornand T; Fontana A; Lienard D; Cerottini J; Tschopp J
Science; 1996 Nov; 274(5291):1363-6. PubMed ID: 8910274
[TBL] [Abstract][Full Text] [Related]
28. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
[TBL] [Abstract][Full Text] [Related]
29. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
30. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus.
Hunt JS; Vassmer D; Ferguson TA; Miller L
J Immunol; 1997 May; 158(9):4122-8. PubMed ID: 9126971
[TBL] [Abstract][Full Text] [Related]
31. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
[TBL] [Abstract][Full Text] [Related]
32. Fas ligand-induced apoptosis as a mechanism of immune privilege.
Griffith TS; Brunner T; Fletcher SM; Green DR; Ferguson TA
Science; 1995 Nov; 270(5239):1189-92. PubMed ID: 7502042
[TBL] [Abstract][Full Text] [Related]
33. Expression of functional Fas ligand in choriocarcinoma.
Hammer A; Hartmann M; Sedlmayr P; Walcher W; Kohnen G; Dohr G
Am J Reprod Immunol; 2002 Oct; 48(4):226-34. PubMed ID: 12516633
[TBL] [Abstract][Full Text] [Related]
34. Induction of apoptosis in placentas of pregnant mice exposed to lipopolysaccharides: possible involvement of Fas/Fas ligand system.
Ejima K; Koji T; Tsuruta D; Nanri H; Kashimura M; Ikeda M
Biol Reprod; 2000 Jan; 62(1):178-85. PubMed ID: 10611083
[TBL] [Abstract][Full Text] [Related]
35. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
36. 3,5,3'-Triiodothyronine down-regulates Fas and Fas ligand expression and suppresses caspase-3 and poly (adenosine 5'-diphosphate-ribose) polymerase cleavage and apoptosis in early placental extravillous trophoblasts in vitro.
Laoag-Fernandez JB; Matsuo H; Murakoshi H; Hamada AL; Tsang BK; Maruo T
J Clin Endocrinol Metab; 2004 Aug; 89(8):4069-77. PubMed ID: 15292350
[TBL] [Abstract][Full Text] [Related]
37. Expression of Fas-ligand in first trimester and term human placental villi.
Hammer A; Dohr G
J Reprod Immunol; 2000 Mar; 46(2):83-90. PubMed ID: 10706940
[TBL] [Abstract][Full Text] [Related]
38. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
39. Regulation of human trophoblast proliferation and apoptosis during pregnancy.
Maruo T; Ishihara N; Samoto T; Murakoshi H; Laoag-Fernandez JB; Matsuo H
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):28-9. PubMed ID: 11753500
[TBL] [Abstract][Full Text] [Related]
40. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
